- Documentotemplate_-_bcp_generalcaricato daGurukrushna Patnaik
- DocumentoMerchantscaricato daGurukrushna Patnaik
- Documento1519247204_apteka_ participants_profile1caricato daGurukrushna Patnaik
- DocumentoForm_MGT_9_FY_201819caricato daGurukrushna Patnaik
- DocumentoEvaluatePharma_World_Preview_2019.pdfcaricato daGurukrushna Patnaik
- Documentoey-the-chemical-industry-reimagined-vision-2025.pdfcaricato daGurukrushna Patnaik
- DocumentoRC-LOGO-HOLDERS.pdfcaricato daGurukrushna Patnaik
- Documentoin-fs-deloitte-banking-colloquium-thoughtpaper-cii.pdfcaricato daGurukrushna Patnaik
- DocumentoPHARMACEUTICAL ORGANISATION SRUCTURE AND FUNCTIONS.pdfcaricato daGurukrushna Patnaik
- Documentoey-the-chemical-industry-reimagined-vision-2025.pdfcaricato daGurukrushna Patnaik
- DocumentoAnnual Report 2018-19 newcaricato daGurukrushna Patnaik
- Documento2019 Q3_EN_LXS_web.pdfcaricato daGurukrushna Patnaik
- DocumentoGAVLInvestorPresentationQ3FY2020caricato daGurukrushna Patnaik
- Documento2019 Q3_EN_LXS_web.pdfcaricato daGurukrushna Patnaik
- DocumentoMylan_A4Factsheet_ININNONP2099_EN_V15.0caricato daGurukrushna Patnaik
- DocumentoThe Importance of an SLA in RPOcaricato daGurukrushna Patnaik
- DocumentoPwc Report Nbfccaricato daGurukrushna Patnaik